within 2 hours of one other for each patient to identify ureteral patency, the primary outcome for this study. Results from both imaging studies were reviewed in a blinded fashion by two experienced radiologists and compared.
INTRODUCTION AND OBJECTIVES:
We evaluate intervention rates and survival outcomes of complex renal cysts in a single center experience. Outcomes stratified by initial classification according to the Bosniak classification system. METHODS: We used a radiology data-mining system (Montage; Montage Healthcare Systems, Philadelphia, PA, USA) to retrospectively review the radiology database in an academic health center between 2001 and 2013 to identify all cases of "complex cyst." Primary end points were overall (OS) and cancer specific survival (CSS).
RESULTS: 248 patients were identified using the Montage system to have radiographic reports of complex renal cysts. Of these, 141 (56.9%), 86 (34.7%), and 21 (8.4%) had Bosniak 2F, 3 and 4 cysts, respectively. Median follow-up was 66.05AE54.24 months with an average of 3.61 scans (all modalities) per year. Of the 244 patients for whom we had follow-up, there were no cancerspecific deaths and overall mortality was 7.4%. Only 1 patient (4.7%) with a Bosniak 4 lesion at diagnosis developed metastases during follow-up. 20 patients underwent percutaneous biopsy of a solid nodule within the cyst; 7 (35%) were found to have renal cell carcinoma, and all of these patients received treatment. With regards to intervention, 6 (4.3%), 31 (36.0%) and 13 (61.9%) of the Bosniak 2F, 3 and 4 patients underwent either surgical or ablative intervention, respectively. Indication for intervention was predominantly age (median age: intervention 50.3AE14.6, no intervention 63.4AE13.3). Median time to intervention from initial identification was 6.45 months. Extirpative surgery with radical (17 patients, 34%) or partial nephrectomy (30 patients, 60%) was the predominant intervention, while 3 patients (6%) underwent ablation. While 4 patients (8.5%) had benign final pathology, the remainder had RCC: 23 (48.9%) clear cell RCC, 10 (21.2%) multilocular cystic RCC, 7 (14.9%) papillary type 1 RCC, 3 (6.4%) papillary type II RCC and 1 (2.1%) tubulocystic RCC. The majority (95.1%) were Fuhrman grade 1 or 2; 2 patients (4.9%) were Fuhrman grade 3. None of the patients undergoing intervention had evidence of recurrence during follow-up. Even when excluding patients undergoing intervention, CSS remained 100%.
CONCLUSIONS: Cancer-specific survival and overall survival for patients diagnosed with Bosniak 2F-4 complex renal cysts remains quite high; there were no cancer-specific deaths, even in the group that received no intervention. Reconsideration of management guidelines for complex renal cysts based on Bosniak classification system is warranted, particularly for Bosniak 3 cysts. METHODS: Men presented for prostate biopsy were randomized to receive ciprofloxacin 500mg B.I.D for 3days from the night of biopsy (group A), augmented prophylaxis using ciprofloxacin and single prebiopsy shot of 160mg gentamycin IM (group B) and rectal swab culture based prophylaxis (group C). Primary end point is occurrence of postprocedure sepsis[ge]2 of SIRS (systemic inflammatory response syndrome) criteria. Inflammatory markers were used for postprocedure screening; CRP (C reactive protein), ESR (Erythrocyte sedimentation rate) and TLC (total leucocyte count). Secondary endpoint is occurrence of FQ-R in the screened men. Men were assessed 2 weeks prior to biopsy, at time of biopsy and 2 weeks after.
Source of
RESULTS: Since November 2015, 258patients were randomized 89, 94 and 80 patients in groups A, B and C respectively. Baseline data was comparable among the 3 groups including prebiopsy urine culture with significant growth in 8 (8.9%), 8 (8.5%) and 10 (12%) in groups A, B and C respectively (P 0.6) and were treated before biopsy. Postprocedure fever occurred in 19 (21.3%), 9 (9.5%) and 8 (10%) in groups A, B and C respectively (P 0.03). Sepsis was reported in 5 (5.6%), 5 (5.3%) and 4 (5%) in groups A, B and C respectively (P 0.9) and 2 (2.2%) patients in group A required hospitalization. Figure 1 shows that the degree of change in TLC and ESR-1stH group was significantly more in group A than other groups (P 0.04 and 0.02 respectively). Urine culture 2 weeks after biopsy showed significant growth in 23 (25.8%), 5 (5.3%) and 11 (13.7%) in groups A, B and C respectively (P 0.002)Significant bacterial growth was noted in 62 (77.5%) out of 80 rectal swabs, FQ-R was reported in 55/62 (88.2%).
CONCLUSIONS: With increasing FQ-R, ciprofloxacin alone is not an optimal prophylactic approach. Augmented prophylaxis with single dose gentamycin is an effective approach. Targeted prophylaxis might be used when gentamycin is contraindicated. 
PD11-08 COMPUTER-AIDED DIAGNOSIS OF PROSTATE CANCER USING A DEEP NEURAL NETWORKS ALGORITHM IN PRE-BIOPSY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING
Junichiro Ishioka*, Yoh Matsuoka, Masaya Itoh, Masaharu Inoue, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii, Hiroshi Tanaka, Tomo Kimura, Tokyo, Japan INTRODUCTION AND OBJECTIVES: Magnetic resonance imaging (MRI) provides a noninvasive assessment of the prostate that improves the detection of prostate cancer and can reduce unnecessary biopsies. The excessive variation in the performance and interpretation of MRI is, however, a major barrier to its widespread acceptance and use. In this study, we employed computer-aided diagnosis with a deep neural networks algorithm for prostate cancer detection using multiparametric MRI (mpMRI).
METHODS: Between 2010 and 2015, 354 patients underwent extended systematic prostate biopsy with MRI-targeted biopsy (MTB), and 209 patients with negative mpMRI underwent systematic prostate biopsy (SB). All patients with PSA levels of less than 20 ng/ ml and negative findings of digital rectal examination were included as subjects. mpMRI was interpreted by an experienced radiologist. For the supervised training using deep neural network architecture, we selected 163 mpMRI-positive patients who were diagnosed with prostate cancer by MTB and 135 mpMRI-negative patients who were not diagnosed with prostate cancer by SB. We chose representative T2-weighted and diffusion-weighted (DW) MRI images from both mpMRI-positive and mpMRI-negative patients. The 298 pairs of T2-weighted and DW images labeled as 00 cancer 00 or 00 no cancer 00 were randomly divided into 248 training and 50 test datasets, and the measure of diagnostic accuracy was calculated. The structure of the deep neural network model we used contains an input layer, three fully connected hidden layers, and an output layer (figure 1). The layers in the networks have ReLu non-linear activation units, and their learning rate was 0.01 for 10 epochs with a dropout ratio of 0.5. RESULTS: In the 50 hold-out validation test datasets, the mean area under the curve and the accuracy were 0. 84 (0.72-0.99) and 0.81 (0.72-0.96) . The mean positive predictive value, negative predictive value, sensitivity, and specificity of the algorithm were 0.89 (0.74-1.00), 0.75 (0.50-1.00), 0.76 (0.50-1.00), and 0.88 (0.18-1.00), respectively.
CONCLUSIONS: Computer-aided diagnosis with a deep neural networks algorithm for prostate cancer with mpMRI can provide reproducible interpretation and a greater level of standardization and consistency.
Source of Funding: none

PD11-09 THE ACCURACY OF REAL-TIME MRI-TRUS FUSION IMAGE-GUIDED TRANSPERINEAL TARGET BIOPSY WITH NEEDLE TRACKING OF MECHANICAL POSITION-ENCODED STEPPER IN THE DETECTION OF THE SIGNIFICANT PROSTATE CANCER FOR THE BIOPSY NA € IVE MEN
Sunao Shoji*, Shinichiro Hiraiwa, Takahiro Ogawa, Masanori Kawakami, Mayura Nakano, Hidenori Zakoji, Toyoaki Uchida, Takuma Tajiri, Tokyo, Japan INTRODUCTION AND OBJECTIVES: To evaluate the accuracy of real-time elastic fusion image-guided transperineal prostate biopsy with needle tracking of mechanical position-encoded stepper in the detection of the significant prostate cancer for the biopsy naive men.
METHODS: The patients with PSA level less than 20 ng/ml who were suspected as having prostate cancer from mpMRI scans were recruited prospectively. Target biopsies for each cancer-suspicious lesion real-time elastic fusion image-guided transperineal prostate biopsy with needle tracking of mechanical position-encoded stepper (Figure) and 12-cores systematic biopsies using the BioJet â system (D&K Technologies GmbH, Barum, Germany). Pathological findings of biopsy cores and whole mount specimen were analyzed. RESULTS: Two hundred fifty patients were included in the present study. Biopsy-proven significant cancer detection rate in the patients was 59% (148 of 250 patients). There was significantly different of the cancer detection rates in the patients between the target (58%, 145 of 250 patients) and systematic biopsy (34%, 86 of 250 patients) (p<0.0001). In targeted biopsy cores (n¼527), biopsyproven significant cancer detection rates (36% vs. 2.1%, p<0.0001), median positive core length (median 8mm vs. median 2mm, p<0.0001), median positive core percent (50% vs. 10%, p<0.0001), and median Gleason score (p<0.0001) were significantly higher compared with the results in systematic biopsy cores (n¼3000). Biopsy-proven significant cancer detection rates of the targeted lesions with the Prostate Imaging and Reporting and Data System classification 3, 4, and 5 were 6.8%, 49%, and 80%, respectively.
